PHI News Room
All News and Press Releases
Enter any phrase or word you would like to search for and click .
PostNews: Press Release
Bulletin from extraordinary general meeting in Phase Holographic Imaging PHI AB (publ) 2 December 2024
Today, 2 December 2024, an Extraordinary General Meeting was held in Phase Holographic Imaging PHI AB (publ), 556542-7811 (the “Company”). The adopted resolution is summarized below.
PostNews: Press Release
Altium SA places order to a value of EUR 460 K and PHI communicates sales outlook
PHI AB today announces that the Company’s global distributor Altium SA has placed an order of HoloMonitor® systems and add-ons to a total value of approximately EUR 460 K. The total expected order value from Altium for the full fiscal year of 2024/2025 is estimated to amount to approximately EUR 2 million.
PostNews: Interim Report
Interim Report 2 2024/25
Sales grew significantly in Q2 vs. the same period last year, but only moderately YTD vs. the same period last year. Discounting on demo kits for our new distributors reduced the gross margin. Overall costs remain stable. The absolute key to transforming the company, both short-term and long-term, is a significant increase in sales, which the agreement with Altium promises to deliver.
PostNews: Press Release
Early publication of Interim Report 2, 2024/2025
Phase Holographic Imaging PHI AB (publ) hereby announces that the Board of Directors has decided to bring forward the company’s report for Q2, 2024/2025 to November 28, 2024. This is because the company wishes to publish the report prior to the Extraordinary General Meeting planned for Dec 2.
PostNews: Press Release
Notice of extraordinary general meeting in Phase Holographic Imaging PHI AB 2 December 2024
Phase Holographic Imaging PHI AB (publ), 556542-7811 (the “Company”) will hold an Extraordinary General Meeting on 2 December 2024 at 15.00 CET at the Company’s premises, Skiffervägen 48 in Lund.
PostNews: Press Release
PHI resolves on a fully secured rights issue of shares of approximately SEK 64.3 million
The Board of Directors of Phase Holographic Imaging PHI AB has today resolved on a rights issue of shares, with preferential rights for the Company’s existing shareholders, of approximately SEK 64.3 million before deduction of issue related costs, subject to approval by the extraordinary general meeting to be held on 2 December 2024. The purpose of the Rights Issue is to fund a strategic development plan and to strengthen the Company’s capital structure by repayment/off-setting of outstanding loans.
Company News
Here, you see PHI featured in recent news and find previous CEO commentaries.
BioStock: PHI “We aim to revolutionize the regenerative medicine market“
BioStock talked to PHI’s CEO, Patrik Eschricht, about the eventful past year and his vision for the company’s future within regenerative medicine.
BioStock: PHI’s CEO reflects on the Company’s momentum
BioStock reached out to PHI’s CEO, Patrik Eschricht, to delve into what latest developments have contributed to the heightened enthusiasm surrounding the company.
BioStock: Altium fuels PHI’s forward drive
BioStock connects with Goran Dubravčić, Altium’s CEO and PHI’s newly appointed Chairman of the Board, to explore the current pivotal developments and their impact on PHI’s trajectory.
BioStock: PHI links up with two regenerative medicine networks
BioStock contacted CEO Patrik Eschricht to learn more about the company’s future strategies in regenerative medicine and the pivot toward the clinical market.
